Paper55271
Studies of "potentially lethal damage" in EMT6 mouse tumour cells treated with bleomycin either in vitro or in vivo.
Twentyman PR and 1 other. Br J Cancer, 1975. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. Studies of "potentially lethal damage" in EMT6 mouse tumour cells treated with bleomycin either in vitro or in vivo. Papers, record 55271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/55271
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Studies of "potentially lethal damage" in EMT6 mouse tumour cells treated with bleomycin either in vitro or in vivo.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bleomycin | Major topic |
| Neoplasms, Experimental | Major topic |
| Animals | |
| Cell Line | |
| Cell Survival | |
| Cells, Cultured | |
| Culture Media | |
| Dose-Response Relationship, Drug | |
| Methods | |
| Mice | |
| Temperature | |
| Time Factors | |
| Trypsin |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4121931 | Response of solid tumor cells exposed to chemotherapeutic agents in vivo: cell survival after 2- and 24-hour exposure. | J Natl Cancer Inst | 1973 | https://conductscience.org/library/papers/4121931 | PubMed |
| 2 | 4128424 | Cell survival and repair of plateau-phase cultures after chemotherapy--relevance to tumor therapy and to the in vitro screening of new agents. | Cancer Chemother Rep | 1973 | https://conductscience.org/library/papers/4128424 | PubMed |
| 3 | 4135125 | The effect of bleomycin and radiation in combination on bacteria and mammalian cells in culture. | Br J Radiol | 1974 | https://conductscience.org/library/papers/4135125 | PubMed |
| 4 | 4138662 | Radioautographic studies on the intracellular distribution of bleomycin-14C in mouse tumor cells. | Cancer Res | 1974 | https://conductscience.org/library/papers/4138662 | PubMed |
| 5 | 4138969 | Potentiation of bleomycin by an antifungal polyene, pentamycin, in transformed animal cells. | Cancer Res | 1974 | https://conductscience.org/library/papers/4138969 | PubMed |
| 6 | 4142871 | Demonstration of repair of potentially lethal damage in plateau phase cells of Ehrlich ascites tumor after exposure to bleomycin. | Gan | 1974 | https://conductscience.org/library/papers/4142871 | PubMed |
| 7 | 5793240 | Potentially lethal radiation damage: repair by mammalian cells in culture. | Science | 1969 | https://conductscience.org/library/papers/5793240 | PubMed |
| 8 | 4224300 | Repair of potentially lethal damage in x-irradiated HeLa cells. | Radiat Res | 1966 | https://conductscience.org/library/papers/4224300 | PubMed |
| 9 | 4647494 | Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. | J Natl Cancer Inst | 1972 | https://conductscience.org/library/papers/4647494 | PubMed |
| 10 | 4678087 | Plateau-phase cultures of mammalian cells: an in vitro model for human cancer. | Curr Top Radiat Res Q | 1972 | https://conductscience.org/library/papers/4678087 | PubMed |
| 11 | 4684814 | Repair of potentially lethal radiation damage in vitro and in vivo. | Radiology | 1973 | https://conductscience.org/library/papers/4684814 | PubMed |
| 12 | 47265 | Studies on recovery from chemically induced damage in mammalian cells. | Cancer Res | 1975 | https://conductscience.org/library/papers/47265 | PubMed |
| 13 | 5315187 | Repair of potentially-lethal radiation damage in mammalian cells: enhancement by conditioned medium from stationary cultures. | Int J Radiat Biol Relat Stud Phys Chem Med | 1971 | https://conductscience.org/library/papers/5315187 | PubMed |
| 14 | 4143273 | The sensitivity to bleomycin of a solid mouse tumour at different stages of growth. | Br J Cancer | 1974 | https://conductscience.org/library/papers/4143273 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7437290 | Response and recovery kinetics of a solid tumour after irradiation. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7437290 | PubMed |
| 7387851 | Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7387851 | PubMed |
| 6466543 | Preclinical pharmacokinetics of benznidazole. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6466543 | PubMed |
| 6208924 | Inhibition of the recovery from potentially lethal damage by lonidamine. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6208924 | PubMed |
| 6199035 | New type of recovery in HeLa cells exposed to bleomycin. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6199035 | PubMed |
| 6177286 | Modulation of bleomycin cytotoxicity. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6177286 | PubMed |
| 3940216 | CB 1954 revisited. I. Disposition kinetics and metabolism. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3940216 | PubMed |
| 921888 | Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. | Br J Cancer | 1977 | https://conductscience.org/library/papers/921888 | PubMed |
| 856237 | Interaction of hyperthermia and the hypoxic cell sensitizer Ro-07-0582 on the EMT6 mouse tumour. | Br J Cancer | 1977 | https://conductscience.org/library/papers/856237 | PubMed |
| 836758 | Sensitivity to cytotoxic agents of the EMT6 tumour in vivo: tumour volume versus in vitro plating. 1. Cyclophosphamide. | Br J Cancer | 1977 | https://conductscience.org/library/papers/836758 | PubMed |
| 831758 | Separation of clonogenic tumour cells from EMT6 mouse mammary tumours. | Br J Cancer | 1977 | https://conductscience.org/library/papers/831758 | PubMed |
| 508562 | Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice. | Br J Cancer | 1979 | https://conductscience.org/library/papers/508562 | PubMed |
| 73379 | An artefact in clonogenic assays of bleomycin cytotoxicity. | Br J Cancer | 1977 | https://conductscience.org/library/papers/73379 | PubMed |
| 72561 | Synergism of X-rays and bleomycin on Ehrlich ascites tumour cells. | Br J Cancer | 1977 | https://conductscience.org/library/papers/72561 | PubMed |
| 57788 | The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour. | Br J Cancer | 1976 | https://conductscience.org/library/papers/57788 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/55271
GET https://conductscience.org/api/papers/v1/55271/authors